KUALA LUMPUR – On Nov 17, Malaysia announced that it had entered into an agreement with China to engage in the promotion of a safe and efficient antibody vaccine as part of efforts to tackle the COVID-19 pandemic. Under the deal, in effect for an initial duration of five years, priority access to COVID-19 vaccines produced by China will be …